United Therapeutics Corpo...
(UTHR)
undefined
undefined%
At close: undefined
361.81
0.12%
After-hours Dec 13, 2024, 05:19 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | 984.80M | 727.30M | 475.80M | 514.80M | -104.50M | 589.20M | 417.90M | 713.70M | 651.60M | 340.10M | 174.56M | 304.44M | 217.87M | 105.92M | 19.46M | -42.79M | 19.86M | 73.97M | 65.02M | 15.45M | -9.97M | -23.65M | -37.29M | -75.61M | -33.50M | -12.80M |
| Depreciation & Amortization | 53.20M | 51.30M | 49.90M | 49.90M | 45.90M | 35.90M | 31.00M | 31.60M | 32.90M | 32.20M | 31.26M | 27.14M | 20.54M | 17.92M | 11.39M | 4.54M | 957.00K | 1.46M | 2.41M | 2.28M | 2.33M | 3.13M | 3.51M | -79.74K | -1.30M | - |
| Stock-Based Compensation | 39.10M | 106.80M | 138.50M | 163.80M | 45.40M | -26.40M | 73.50M | 12.10M | 280.25M | 190.05M | 320.79M | 30.11M | -15.71M | 113.94M | 101.02M | 28.70M | -29.60M | -10.76M | - | - | - | - | - | - | - | - |
| Other Working Capital | -82.80M | -150.60M | -112.90M | 16.80M | 16.30M | 4.70M | -61.40M | -71.80M | -181.82M | -322.08M | -201.75M | -145.76M | -95.70M | -39.43M | -18.73M | -2.89M | 1.65M | 7.71M | -1.70M | 1.80M | -1.85M | 355.00K | -1.63B | 3.86M | 1.80M | - |
| Other Non-Cash Items | -1.30M | 23.90M | 72.50M | 191.00M | -148.00M | 153.30M | 25.30M | -101.70M | -301.70M | -17.00M | 219.45M | -7.96M | 336.35M | 6.64M | 20.18M | -19.07M | 66.94M | 27.41M | -16.23M | 1.64M | 2.14M | 11.40M | 2.06M | 42.83M | 9.30M | 2.00M |
| Deferred Income Tax | - | -71.70M | -89.70M | -168.10M | -82.70M | -104.30M | - | - | - | 185.11M | 104.34M | 136.23M | -197.59M | 41.92M | -1.04M | -31.21M | -3.28M | -37.05M | -18.13M | - | - | - | - | - | - | - |
| Change in Working Capital | -97.80M | -35.10M | -48.80M | 4.30M | 37.30M | 130.70M | -83.20M | -46.20M | -37.30M | -56.70M | -22.42M | -29.92M | -111.25M | -74.81M | -53.39M | 10.66M | -5.79M | -3.25M | -7.50M | 1.42M | -3.05M | -13.14M | -7.19M | 1.74M | 1.80M | 1.20M |
| Operating Cash Flow | 978.00M | 802.50M | 598.20M | 755.70M | -206.60M | 778.40M | 474.20M | 643.60M | 382.80M | 355.30M | 425.27M | 323.63M | 250.19M | 211.53M | 97.62M | -49.17M | 49.08M | 51.78M | 43.70M | 20.78M | -8.56M | -22.26M | -38.90M | -31.11M | -23.70M | -9.60M |
| Capital Expenditures | -230.40M | -138.80M | -120.80M | -59.30M | -83.70M | -184.40M | -86.30M | -43.20M | -49.79M | -47.44M | -31.91M | -111.91M | -35.98M | -18.64M | -95.40M | -124.42M | -38.66M | -15.63M | -6.12M | -5.22M | -7.00M | -3.58M | -687.29K | -639.88K | -2.30M | -1.00M |
| Acquisitions | -89.20M | 7.10M | 366.10M | 681.60M | -20.50M | -124.10M | 8.30M | -2.10M | - | - | -30.77M | - | -3.55M | - | 1.21M | -266.05M | -260.89M | -32.36M | - | 821.00K | - | 1K | - | -8.13M | - | - |
| Purchase of Investments | -2.51B | -1.71B | -1.90B | -2.31B | -1.28B | -867.00M | -830.60M | -38.90M | -117.00M | -163.67M | -762.20M | -579.32M | -815.68M | -662.23M | -310.63M | -345.96M | -301.99M | -207.15M | -78.06M | -37.47M | -44.71M | -11.22M | -152.52M | -56.66M | -114.30M | -10.50M |
| Sales Maturities Of Investments | 2.14B | 1.03B | 1.53B | 1.63B | 1.04B | 400.90M | 72.90M | 130.40M | 320.37M | 549.58M | 529.90M | 527.86M | 733.88M | 457.73M | 249.08M | 297.90M | 318.94M | 118.76M | 12.90M | 30.00M | - | 140.57M | 18.39M | 76.45M | 92.60M | - |
| Other Investing Acitivies | -23.00M | 3.50M | -366.10M | -679.20M | 8.00M | -636.20M | -749.30M | 86.30M | 553.40M | 385.90M | -263.06M | -51.46M | -1K | 13.90M | -4.78M | 266.05M | 260.89M | 32.36M | - | -1.00M | 4.18M | -5.41M | 40.00K | -3.87M | -100.00K | - |
| Investing Cash Flow | -719.60M | -811.50M | -486.90M | -738.50M | -335.40M | -820.60M | -835.60M | 48.30M | 503.60M | 338.50M | -294.97M | -163.36M | -121.33M | -209.24M | -160.52M | -172.48M | -21.71M | -104.03M | -71.28M | -12.87M | -47.54M | 120.36M | -134.78M | 7.16M | -24.10M | -11.50M |
| Debt Repayment | -100.00M | - | - | -50.00M | 600.00M | - | 250.00M | -8.80M | -133.20M | -177.80M | -1.32M | -999.00K | -8.57M | 38.56M | - | -23.00K | -10.00K | 242.01M | -795.00K | -774.00K | -2.08M | -60.00K | -80.00K | -58.52K | 1.10M | - |
| Common Stock Repurchased | -13.80M | -11.40M | -10.80M | -3.70M | -2.10M | - | -250.00M | -500.00M | -394.50M | -483.10M | -42.44M | -188.00M | -212.00M | - | - | - | -67.06M | -193.09M | - | - | - | - | -2.80M | -4.07M | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -29.60M | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 101.90M | 86.80M | 55.60M | 36.80M | 13.30M | 6.30M | 43.30M | 11.10M | 80.70M | 84.30M | 38.64M | 19.86M | 2.49M | 108.20M | 36.48M | 63.03M | 87.95M | 10.76M | - | - | - | - | -299 | 159.42K | -200.00K | - |
| Financial Cash Flow | -11.90M | 75.40M | 44.80M | -16.90M | 611.20M | 6.30M | 43.30M | -497.70M | -447.00M | -576.60M | -5.12M | -169.14M | -218.08M | 146.76M | 36.48M | 213.00M | 20.88M | 74.13M | 14.17M | 6.32M | 2.01M | 185.00K | -2.88M | 206.61M | 59.30M | 22.90M |
| Net Cash Flow | 246.50M | 66.40M | 156.10M | 300.00K | 69.20M | -35.90M | -317.90M | 191.20M | 434.10M | 113.44M | 124.86M | -8.65M | -89.49M | 151.81M | -29.10M | -9.87M | 48.26M | 21.89M | -13.41M | 14.22M | -54.09M | 98.28M | -176.56M | 182.66M | 11.50M | 22.90M |
| Free Cash Flow | 747.60M | 663.70M | 477.40M | 696.40M | -290.30M | 594.00M | 387.90M | 600.40M | 333.01M | 307.86M | 393.36M | 211.72M | 214.22M | 192.89M | 2.22M | -173.59M | 10.43M | 36.15M | 37.58M | 15.56M | -15.57M | -25.84M | -39.59M | -31.75M | -26.00M | -10.60M |